Skip to main content
  • COVID-19
    • COVID-19 vaccines and cancer
      • FAQs
      • FAQs in-language
      • SerOzNET Study
    • COVID-19 information for people affected by cancer
      • Managing your cancer care in the context of COVID-19
      • Looking after your mental wellbeing
      • Canada
      • Ireland
      • UK
      • USA
    • COVID-19 information for children and young people with cancer
    • Cancer Won’t Wait
    • Cancer and COVID-19 - what it means for our Mob
      • COVID-19 vaccines: Information for Aboriginal and Torres Strait Islander people affected by cancer
      • Act early for our Mob's health
    • Guidance for health professionals
      • Diagnosis
      • Treatment
      • Surgery
      • Medical oncology
      • Radiation oncology
      • Primary care
      • Telehealth
      • Clinical trials
      • Follow-up care
      • Supportive and Palliative care
      • Cancer care for cancer patients with COVID-19
      • COVID-19 vaccines and cancer
      • Recovery
    • Research articles
      • Review articles
      • Data articles
      • Recommendations articles
      • Shared experience articles
      • COVID-19 vaccines and cancer articles
    • Cancer care in the time of COVID-19: A conceptual framework
    • Optimal cancer care during the COVID-19 pandemic: the Principles
    • The impact of COVID-19 on cancer services
    • COVID-19 Recovery: Implications for cancer care
      • Expanded use of telehealth
      • Changes to prevention and early detection
      • Virtual multidisciplinary team meetings
      • Modifications to treatment schedules
      • Hypofractionated radiotherapy
      • Oncology hospital in the home
      • Responsive patient support
      • Innovative care and hospital infrastructure models
      • Shared follow-up and survivorship care
      • Supportive and palliative care
      • Cancer research and clinical trials
      • Collaboration in the oncology sector and data sharing
      • Acknowledgements
  • About us
    • Organisational structure
    • Accountability and reporting
      • Annual reports
    • Who we work with
      • Roles & functions
      • Advisory Council
      • Advisory groups
      • Consumer engagement
      • Government cancer control organisations
    • Information publication scheme
      • Information publication scheme plan
      • Freedom of information act
        • The FOI request process
      • FOI disclosure log
    • Reconciliation action plan
    • Employment opportunities
  • News and media
    • News
    • Subscribe to our eNewsletter
  • Contact us
Cancer Australia
Choose Language
  • العربية
  • 简体中文
  • 繁體中文
  • Ελληνικά
  • हिन्दी
  • Italiano
  • 한국어
  • Español
  • Tagalog
  • Tiếng Việt
  • العربية
  • 简体中文
  • 繁體中文
  • Ελληνικά
  • हिन्दी
  • Italiano
  • 한국어
  • Español
  • Tagalog
  • Tiếng Việt
  • العربية
  • 简体中文
  • 繁體中文
  • Ελληνικά
  • हिन्दी
  • Italiano
  • 한국어
  • Español
  • Tagalog
  • Tiếng Việt
  • Home
  • Cancer types
  • Impacted by Cancer
  • Awareness
  • Research
  • Resources
  • Clinicians hub
  • Key initiatives
  • Home
  • Cancer types
    • Bladder cancer
    • Bowel cancer
    • Brain cancer
    • Breast cancer
    • Breast cancer in men
    • Breast cancer in young women
    • Cervical cancer
    • Children’s cancer
    • Endometrial cancer
    • Fallopian cancer
    • Gestational trophoblastic disease
    • Gynaecological cancers
    • Head and neck cancer
    • Kidney cancer
    • Leukaemia
    • Liver cancer
    • Lung cancer
    • Lymphoma
    • Melanoma
    • Mesothelioma cancer
    • Myeloma
    • Neuroendocrine tumours
    • Oesophageal cancer
    • Ovarian cancer
    • Pancreatic cancer
    • Prostate cancer
    • Sarcoma
    • Stomach cancer
    • Testicular cancer
    • Thyroid cancer
    • Unknown primary cancer
    • Uterine sarcoma
    • Vaginal cancer
    • Vulvar cancer
  • Impacted by Cancer
    • What is cancer
    • Physical changes
    • Treatment
    • Keeping healthy
    • Emotions
    • Family and relationships
    • Living with cancer
  • Awareness
    • Your cancer risk
    • Screening
    • Interactive body map
  • Research
    • Cancer Research in Australia
    • Data and statistics
    • Australian Clinical Trials
    • Support for cancer clinical trials
    • Grants and funding
  • Resources
    • Cancer Australia Publications
    • Clinical Practice Guidelines
    • Position statements
    • Resources in other languages
    • Cancer Australia websites
    • Cancer risk online assessment tools
    • Other tools and resources
    • Podcasts
    • Cancer support organisations
    • Glossary
  • Clinicians hub
    • GP guides and resources
    • Guidelines by cancer type
    • Optimal cancer care pathways
    • Working with Aboriginal and Torres Strait Islander people
    • Multidisciplinary care
    • Psychosocial care
    • Follow-up care
    • Family cancer clinics
    • Cancer Learning
    • Consumer engagement
  • Key initiatives
    • For Aboriginal and Torres Strait Islander people
    • Australian Cancer Plan
    • Australian Brain Cancer Mission
    • Jeannie Ferris Award
    • Lung Cancer Screening
    • National Pancreatic Cancer Roadmap
    • Campaigns & events

Ovarian cancer

ovarian-mm cancer-types/ovarian-cancer/overview
    • Home
    • Types
    • Statistics
    • Risk factors
    • Screening
    • Symptoms
    • Diagnosis
    • Treatment
    • Family history
    • Finding support
    • Clinical trials
    • Health professionals
    • Awareness
    • Home
    • Types
    • Statistics
    • Risk factors
    • Screening
    • Symptoms
    • Diagnosis
    • Treatment
    • Family history
    • Finding support
    • Clinical trials
    • Health professionals
    • Awareness
  1. Home
  2. Treatment
Loading...

Treatment options

  • Printer-friendly version
  • A|A

Treatment and care of people with cancer is usually provided by a team of health professionals, both medical and allied health, called a multidisciplinary team.

If you’re suspected of having ovarian cancer, you should be referred to a gynaecological oncologist. Research shows survival for women with ovarian cancer is improved when their surgical care is directed by a gynaecological oncologist.

Treatment for ovarian cancer depends on:

  • the stage of the disease
  • the location of the cancer
  • the severity of symptoms
  • your general health and wishes.

Treatment may involve the following.

Surgery

Surgery is usually the initial treatment for ovarian cancer.The aim is to remove as much of the cancer as possible from the body by removing the cancer cells, and organs and tissues that the cancer cells have spread to. This allows adjuvant treatment, such as chemotherapy, to be more effective.

A laparotomy is usually performed – this is a cut through the wall of the abdomen from the belly button to the pelvic bone.

Depending on how far the cancer has spread, the surgery may remove the ovary and attached fallopian tube (or both ovaries and both fallopian tubes if the cancer is in both ovaries), and/or the uterus (in an operation called a hysterectomy). If the cancer has spread outside the pelvis (stages III or IV), other tissues and organs will probably also be removed, as well as lymph nodes that appear abnormal.

For early-stage ovarian cancer or borderline ovarian cancer, a less invasive surgery using laparoscopy (‘keyhole surgery’) might be possible. Laparoscopy involves a number of very small cuts in the abdomen, rather than a single large cut. A laparoscope – a tube with a light at the end – is inserted through one of the cuts to allow the doctor to see inside the abdomen, and surgical instruments are inserted through other cuts to remove tissue.

After the surgery, you may have some pain and tenderness in the pelvis and abdomen for a few days or weeks. Other side effects might include swelling in the legs (lymphoedema), constipation and difficulty urinating. Depending on the extent of the surgery, it might take several weeks for you to fully recover and return to normal activities.

If both ovaries are removed during surgery, you will go through menopause (i.e. your menstrual periods will permanently stop) and may experience symptoms associated with it. These can include hot flushes, night sweats, vaginal dryness and mood swings.

Chemotherapy

Most women with ovarian cancer will have both surgery and post-operative (adjuvant) chemotherapy to eliminate any cancer that remains after surgery.

For some women with stage III or IV ovarian cancer, chemotherapy before surgery (neoadjuvant chemotherapy) may be used to shrink the tumours before surgery.

See more about the types of chemotherapy and possible side effects.

Radiotherapy

Radiotherapy uses high-energy X-rays or other types of radiation to stop cancer cells growing. This treatment is not commonly used to treat ovarian cancer, but it can be used to help relieve symptoms caused by the cancer or when it has come back after treatment (recurred).

See more about the types of radiation therapy and possible side effects.

Targeted therapy

Targeted therapy refers to treatment with medicines that are designed to specifically attack cancer cells without harming normal cells.These types of medicines affect the way that cancer cells grow, divide, repair themselves or interact with other cells.

Medicines that might be considered for targeted therapy for some women with advanced ovarian cancer include bevacizumab and olaparib.

Bevacizumab is a monoclonal antibody that belongs to a class of medicines known as angiogenesis inhibitors. These medicines prevent the formation of new blood vessels that are needed for the cancer to grow and spread.

Olaparib is a different type of medicine, called a PARP inhibitor, that may be used to treat women who have advanced ovarian cancer with mutations (gene faults) in BRCA genes and who have already had treatment with other types of chemotherapy. BRCA genes are involved in repairing damaged DNA and normally work to suppress tumour growth. Olaparib acts by preventing tumour cells with a mutation in a BRCA gene from repairing themselves.

Bevacizumab and olaparib have both been shown to shrink or slow the growth of advanced epithelial ovarian cancers.

See more about the types of targeted therapy and possible side effects.

Hormone therapy

Hormone therapy, which uses hormones or medicines that block the action of hormones, is rarely used for epithelial ovarian cancer (the most common type of ovarian cancer) and is more likely to be used for ovarian stromal tumours.

Medicines used in hormone therapy for ovarian cancer include luteinising-hormone-releasing hormone (LHRH) agonists, tamoxifen and aromatase inhibitors. All of these act by preventing oestrogen from stimulating cancer cell growth (they either reduce the levels of oestrogen or act as anti-oestrogens).

See more about the types of hormone therapy and possible side effects.

Follow-up

Follow-up after treatment for ovarian cancer can be used to check whether the treatment worked, to manage side effects of treatment and to identify whether the cancer has come back (recurred). It also gives the woman the opportunity to talk about psychological and emotional issues. The type and timing of follow-up will be determined by the woman and her doctor, and may include a physical examination of the pelvic area, blood tests and imaging.

Advanced disease

Because there is no screening test to detect ovarian cancer early, most women have advanced disease when they are diagnosed. In advanced (metastatic) ovarian cancer, cancer cells have spread in the bloodstream or lymphatic system to other areas of the pelvis, or to tissues and organs outside the pelvis. Stages II, III and IV of ovarian cancer are treated as advanced cancers.

Surgery for ovarian cancer may remove the uterus, both ovaries and fallopian tubes, omentum (fatty tissue around the organs in the abdomen) and lymph nodes. In advanced cases, the aim of surgery is to reduce the bulk (size) of the tumours, so no visible cancer remains. This is called maximal tumour resection. Research confirms that women have a better prognosis and survival when there is no visible cancer and the surgery is followed by chemotherapy. In many cases, other organs and tissues that the cancer has spread to will be removed, such as the intestines, bladder, diaphragm, liver, spleen, stomach, gall bladder, appendix, pancreas and peritoneum (the membrane lining the walls of the abdomen and pelvis).

Your gynaecological oncologist will discuss the procedure with you in detail before the surgery.

If the cancer is very advanced, maximal resection will not be possible. Other conditions (comorbidities) such as pre-existing heart, lung or other medical conditions may mean that anaesthetic and surgery is not a good option. Chemotherapy may be needed to shrink the tumours.

Recurrent cancer

Ovarian cancer can recur (come back) after treatment. The cancer can recur in the pelvis or somewhere else in the body.

You may have signs and symptoms of recurrence of the cancer, or the recurrence might be detected during blood tests without producing any symptoms.

Treatment options for recurrent ovarian cancer include surgery, chemotherapy and targeted therapy.The type of treatment that is used will depend on the type of recurrence, the time since the first treatment and whether you have previously had chemotherapy.

  • Last Updated
  • Relevant Links
updated: 20 October 2020 - 3:32pm
Cancer Australia, Epithelial ovarian cancer: understanding your diagnosis and treatment
Cancer Australia, Intimacy and sexuality for women with gynaecological cancer – starting a conversation
Cancer Australia Familial Risk Assesment For Breast and Ovarian Cancer
American Cancer Society, Ovarian cancer
National Cancer Institute (US), Ovarian epithelial, fallopian tube, and primary peritoneal cancer treatment (PDQ®), patient vers
National Cancer Institute (US), Ovarian germ cell tumors treatment (PDQ®), patient version
National Cancer Institute (US), Ovarian low malignant potential tumors treatment (PDQ®), patient version
National Comprehensive Cancer Network (US), NCCN guidelines for patients: ovarian cancer
Australian Cancer Trials

Related information

What is cancer?
What is cancer?

Cancer is a disease of the cells, which are the body’s basic building blocks.

Treatment and side effects
Treatment and side effects

The treatment that your doctors recommend will depend on the type of cancer you have, how advanced it is, and other personal factors.

Living with cancer
Living with cancer

A diagnosis of cancer marks the beginning of a journey full of emotional, psychological, physical and practical challenges.

Life after cancer
Life after cancer

While looking forward to finishing their cancer treatment and getting on with life, for some people, the end of treatment can also be a confusing or worrying time.

A-Z List of Cancer Types

Information on more than 70 types of cancer

  • Bladder cancer
  • Bowel cancer
  • Brain cancer
  • Breast cancer
  • Breast cancer in men
  • Breast cancer in young women
  • Cervical cancer
  • Children's Cancer
  • Endometrial cancer
  • Fallopian cancer
  • Gestational trophoblastic disease
  • Gynaecological cancers
  • Head and neck cancer
  • Kidney cancer
  • Leukaemia
  • Liver cancer
  • Lung cancer
  • Lymphoma
  • Melanoma of the skin
  • Mesothelioma cancer
  • Myeloma
  • Neuroendocrine tumours
  • Oesophageal cancer
  • Ovarian cancer
  • Pancreatic cancer
  • Prostate cancer
  • Sarcoma
  • Stomach cancer
  • Testicular cancer
  • Thyroid cancer
  • Unknown primary
  • Uterine sarcoma
  • Vaginal cancer
  • Vulval cancer

About Cancer Australia

Cancer Australia was established by the Australian Government in 2006 to benefit all Australians affected by cancer, and their families and carers. Cancer Australia aims to reduce the impact of cancer, address disparities and improve outcomes for people affected by cancer by leading and coordinating national, evidence-based interventions across the continuum of care.

If you would like an interpreter to help you understand any information on this website, please call TIS National on 131 450 and ask them to call Cancer Australia on 02 9357 9400. Our business hours are 9am to 5pm, Monday to Friday.

Freecall 1800 624 973
+61 2 9357 9400

Locked Bag 3, Strawberry Hills
NSW 2012

Navigation

  • Cancer types
  • Impacted by Cancer
  • Awareness
  • Research
  • Resources
  • Clinicians hub
  • Key initiatives

Contact us

* Denotes mandatory fields
 

By submitting this form, you accept the Cancer Australia privacy policy.

  • Contact Us
  • Copyright
  • Disclaimer
  • Privacy policy
  • Sitemap
Copyright © 2023 - Cancer Australia